The Canadian Network for Observational Drug Effect Studies (CNODES)

Reflections on the first eight years, and a look to the future

Robert W. Platt*, David A. Henry, Samy Suissa

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

[Extract] The Canadian Network for Observational Drug Effect Studies (CNODES—www.cnodes.ca) was established in 2011 as a coordinating center and research network funded by the Drug Safety and Effectiveness Network (DSEN).1 DSEN was formed as a joint initiative of Health Canada and the Canadian Institutes of Health Research (www.cihr‐irsc.gc.ca/e/40269.html), with the overall objective of providing high‐quality and comprehensive information on the safety and effectiveness of pharmaceutical products after they enter the Canadian market. CNODES' primary mission is to use population‐based Canadian and other databases through a distributed network to perform rapid assessments of drug safety and effectiveness. The research questions are usually proposed by Health Canada, the national drug regulator, but can also come other stakeholders such as provincial and territory drug plans. In 2016, funding was granted for an additional five years.
Original languageEnglish
Pages (from-to)103-107
Number of pages5
JournalPharmacoepidemiology and Drug Safety
Volume29
Issue numberS1
Early online date8 Dec 2019
DOIs
Publication statusPublished - 1 Jan 2020

Fingerprint

Pharmaceutical Preparations
Safety
Canada
Health
Drugs
Research
Databases

Cite this

@article{1fd61dce76ae4df5b01f8b2b464e4718,
title = "The Canadian Network for Observational Drug Effect Studies (CNODES): Reflections on the first eight years, and a look to the future",
abstract = "[Extract] The Canadian Network for Observational Drug Effect Studies (CNODES—www.cnodes.ca) was established in 2011 as a coordinating center and research network funded by the Drug Safety and Effectiveness Network (DSEN).1 DSEN was formed as a joint initiative of Health Canada and the Canadian Institutes of Health Research (www.cihr‐irsc.gc.ca/e/40269.html), with the overall objective of providing high‐quality and comprehensive information on the safety and effectiveness of pharmaceutical products after they enter the Canadian market. CNODES' primary mission is to use population‐based Canadian and other databases through a distributed network to perform rapid assessments of drug safety and effectiveness. The research questions are usually proposed by Health Canada, the national drug regulator, but can also come other stakeholders such as provincial and territory drug plans. In 2016, funding was granted for an additional five years.",
author = "Platt, {Robert W.} and Henry, {David A.} and Samy Suissa",
year = "2020",
month = "1",
day = "1",
doi = "10.1002/pds.4936",
language = "English",
volume = "29",
pages = "103--107",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley & Sons",
number = "S1",

}

The Canadian Network for Observational Drug Effect Studies (CNODES) : Reflections on the first eight years, and a look to the future. / Platt, Robert W.; Henry, David A.; Suissa, Samy.

In: Pharmacoepidemiology and Drug Safety, Vol. 29, No. S1, 01.01.2020, p. 103-107.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The Canadian Network for Observational Drug Effect Studies (CNODES)

T2 - Reflections on the first eight years, and a look to the future

AU - Platt, Robert W.

AU - Henry, David A.

AU - Suissa, Samy

PY - 2020/1/1

Y1 - 2020/1/1

N2 - [Extract] The Canadian Network for Observational Drug Effect Studies (CNODES—www.cnodes.ca) was established in 2011 as a coordinating center and research network funded by the Drug Safety and Effectiveness Network (DSEN).1 DSEN was formed as a joint initiative of Health Canada and the Canadian Institutes of Health Research (www.cihr‐irsc.gc.ca/e/40269.html), with the overall objective of providing high‐quality and comprehensive information on the safety and effectiveness of pharmaceutical products after they enter the Canadian market. CNODES' primary mission is to use population‐based Canadian and other databases through a distributed network to perform rapid assessments of drug safety and effectiveness. The research questions are usually proposed by Health Canada, the national drug regulator, but can also come other stakeholders such as provincial and territory drug plans. In 2016, funding was granted for an additional five years.

AB - [Extract] The Canadian Network for Observational Drug Effect Studies (CNODES—www.cnodes.ca) was established in 2011 as a coordinating center and research network funded by the Drug Safety and Effectiveness Network (DSEN).1 DSEN was formed as a joint initiative of Health Canada and the Canadian Institutes of Health Research (www.cihr‐irsc.gc.ca/e/40269.html), with the overall objective of providing high‐quality and comprehensive information on the safety and effectiveness of pharmaceutical products after they enter the Canadian market. CNODES' primary mission is to use population‐based Canadian and other databases through a distributed network to perform rapid assessments of drug safety and effectiveness. The research questions are usually proposed by Health Canada, the national drug regulator, but can also come other stakeholders such as provincial and territory drug plans. In 2016, funding was granted for an additional five years.

UR - http://www.scopus.com/inward/record.url?scp=85076365626&partnerID=8YFLogxK

U2 - 10.1002/pds.4936

DO - 10.1002/pds.4936

M3 - Article

VL - 29

SP - 103

EP - 107

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - S1

ER -